• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度比哈尔邦高度流行村庄内脏利什曼病、无症状感染和皮肤利什曼病后黑热病家庭传播的纵向研究

Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.

作者信息

Das Vidya Nand Ravi, Pandey Ravindra Nath, Siddiqui Niyamat Ali, Chapman Lloyd A C, Kumar Vijay, Pandey Krishna, Matlashewski Greg, Das Pradeep

机构信息

Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna, India.

University of Warwick, Coventry, England.

出版信息

PLoS Negl Trop Dis. 2016 Dec 14;10(12):e0005196. doi: 10.1371/journal.pntd.0005196. eCollection 2016 Dec.

DOI:10.1371/journal.pntd.0005196
PMID:27974858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5156552/
Abstract

BACKGROUND

Visceral Leishmaniasis (VL) is a neglected tropical disease that afflicts some of the poorest populations in the world including people living in the Bihar state of India. Due to efforts from local governments, NGOs and international organizations, the number of VL cases has declined in recent years. Despite this progress, the reservoir for transmission remains to be clearly defined since it is unknown what role post kala-azar dermal leishmaniasis (PKDL) and asymptomatic infections play in transmission. This information is vital to establish effective surveillance and monitoring to sustainably eliminate VL.

METHODOLOGY/PRINCIPAL FINDINGS: We performed a longitudinal study over a 24-month period to examine VL transmission and seroconversion in households with VL, PKDL and asymptomatic infections in the Saran and Muzaffarpur districts of Bihar. During the initial screening of 5,144 people in 16 highly endemic villages, 195 cases of recently treated VL, 116 healthy rK39 positive cases and 31 PKDL cases were identified. Approximately half of the rK39-positive healthy cases identified during the initial 6-month screening period were from households (HHs) where a VL case had been identified. During the 18-month follow-up period, seroconversion of family members in the HHs with VL cases, PKDL cases, and rK39-positive individuals was similar to control HHs. Therefore, seroconversion was highest in HHs closest to the time of VL disease of a household member and there was no evidence of higher transmission in households with PKDL or healthy rK39-positive HHs. Moreover, within the PKDL HHs, (the initial 31 PKDL cases plus an additional 66 PKDL cases), there were no cases of VL identified during the initial screen or the 18-month follow-up. Notably, 23% of the PKDL cases had no prior history of VL suggesting that infection resulting directly in PKDL is more common than previously estimated.

CONCLUSIONS/SIGNIFICANCE: These observations argue that acute VL cases represent the major reservoir for transmission in these villages and early identification and treatment of VL cases should remain a priority for VL elimination. We were unable to obtain evidence that transmission occurs in HHs with a PKDL case.

摘要

背景

内脏利什曼病(VL)是一种被忽视的热带疾病,折磨着世界上一些最贫困的人群,包括生活在印度比哈尔邦的人们。由于地方政府、非政府组织和国际组织的努力,近年来VL病例数量有所下降。尽管取得了这一进展,但传播源仍有待明确界定,因为尚不清楚黑热病后皮肤利什曼病(PKDL)和无症状感染在传播中所起的作用。这些信息对于建立有效的监测以可持续消除VL至关重要。

方法/主要发现:我们在24个月期间进行了一项纵向研究,以调查比哈尔邦萨兰和穆扎法尔布尔地区有VL、PKDL和无症状感染的家庭中的VL传播和血清转化情况。在对16个高度流行村庄的5144人进行初步筛查时,确定了195例近期接受治疗的VL病例、116例健康的rK39阳性病例和31例PKDL病例。在最初6个月的筛查期内确定的rK39阳性健康病例中,约有一半来自已确诊有VL病例的家庭(HHs)。在18个月的随访期内,有VL病例、PKDL病例和rK39阳性个体的家庭中家庭成员的血清转化情况与对照家庭相似。因此,血清转化在最接近家庭成员VL疾病发生时间的家庭中最高,并且没有证据表明PKDL家庭或健康的rK39阳性家庭中有更高的传播率。此外,在PKDL家庭中(最初的31例PKDL病例加上另外66例PKDL病例),在初步筛查或18个月随访期间未发现VL病例。值得注意的是,23%的PKDL病例没有VL病史,这表明直接导致PKDL的感染比以前估计的更为常见。

结论/意义:这些观察结果表明,急性VL病例是这些村庄传播的主要来源,早期识别和治疗VL病例仍应是消除VL的优先事项。我们无法获得证据证明有PKDL病例的家庭中会发生传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/5156552/a0391f6ef302/pntd.0005196.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/5156552/a0391f6ef302/pntd.0005196.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad6d/5156552/a0391f6ef302/pntd.0005196.g001.jpg

相似文献

1
Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.印度比哈尔邦高度流行村庄内脏利什曼病、无症状感染和皮肤利什曼病后黑热病家庭传播的纵向研究
PLoS Negl Trop Dis. 2016 Dec 14;10(12):e0005196. doi: 10.1371/journal.pntd.0005196. eCollection 2016 Dec.
2
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.在印度比哈尔邦,采用20毫克/千克脂质体两性霉素B(安必素)治疗原发性内脏利什曼病后出现的黑热病后皮肤利什曼病。
PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2611. doi: 10.1371/journal.pntd.0002611. eCollection 2014.
3
Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site.穆扎法普尔健康和人口监测点的黑热病后皮肤利什曼病和麻风病的患病率和分布情况。
PLoS Negl Trop Dis. 2019 Oct 25;13(10):e0007798. doi: 10.1371/journal.pntd.0007798. eCollection 2019 Oct.
4
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
5
Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.推断传播树以指导针对内脏利什曼病和黑热病后皮肤利什曼病的干预措施。
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25742-25750. doi: 10.1073/pnas.2002731117. Epub 2020 Sep 24.
6
Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.印度慢性砷暴露与黑热病后皮肤利什曼病发生风险:一项回顾性队列研究
PLoS Negl Trop Dis. 2016 Oct 24;10(10):e0005060. doi: 10.1371/journal.pntd.0005060. eCollection 2016 Oct.
7
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.印度比哈尔邦三种不同内脏利什曼病治疗方案后复发和黑热病后皮肤利什曼病的长期发病率。
PLoS Negl Trop Dis. 2020 Jul 20;14(7):e0008429. doi: 10.1371/journal.pntd.0008429. eCollection 2020 Jul.
8
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.通过在印度比哈尔邦实施基于卫生机构的哨点监测系统,改善黑热病病例管理。
PLoS Negl Trop Dis. 2021 Aug 24;15(8):e0009598. doi: 10.1371/journal.pntd.0009598. eCollection 2021 Aug.
9
PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.皮肤利什曼病后皮肤黏膜利什曼病——印度西孟加拉邦马尔达地区黑热病流行区利什曼病传播的一个隐匿寄生虫库
PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004138. doi: 10.1371/journal.pntd.0004138. eCollection 2015.
10
Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India.印度西孟加拉邦马尔达地区黑热病流行区的无症状利什曼病。
PLoS Negl Trop Dis. 2017 Feb 10;11(2):e0005391. doi: 10.1371/journal.pntd.0005391. eCollection 2017 Feb.

引用本文的文献

1
Association of Post Kala-Azar Dermal Leishmaniasis pathogenesis with prolonged sunlight (ultraviolet radiations) exposure in VL endemic population of Bihar.比哈尔邦内脏利什曼病(VL)流行地区,黑热病后皮肤利什曼病的发病机制与长期暴露于阳光(紫外线辐射)之间的关联。
Sci Rep. 2025 Jul 17;15(1):25916. doi: 10.1038/s41598-025-08738-0.
2
AI-driven analysis by identifying risk factors of VL relapse in HIV co-infected patients.通过识别合并感染HIV患者中VL复发的危险因素进行人工智能驱动的分析。
Sci Rep. 2025 Jul 1;15(1):21067. doi: 10.1038/s41598-025-07406-7.
3
Antimony susceptible : evidence from drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.

本文引用的文献

1
Repeated training of accredited social health activists (ASHAs) for improved detection of visceral leishmaniasis cases in Bihar, India.对印度比哈尔邦经认可的社会健康活动者(ASHAs)进行反复培训,以提高对内脏利什曼病病例的检测能力。
Pathog Glob Health. 2016;110(1):33-5. doi: 10.1080/20477724.2016.1156902.
2
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India.了解杜氏利什曼原虫的传播动态,为印度比哈尔邦消除内脏利什曼病的干预措施提供有力证据。
Parasit Vectors. 2016 Jan 27;9:25. doi: 10.1186/s13071-016-1309-8.
3
Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent.
锑敏感:来自前米替福新时代和后米替福新时代间,从卡拉巴肿后皮肤利什曼病患者分离的寄生虫药物敏感性获得的证据。
Microbiol Spectr. 2024 Jun 4;12(6):e0402623. doi: 10.1128/spectrum.04026-23. Epub 2024 May 7.
4
Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India.在印度内脏利什曼病消除计划中使用模型证据面临的挑战。
PLOS Glob Public Health. 2022 Nov 29;2(11):e0001049. doi: 10.1371/journal.pgph.0001049. eCollection 2022.
5
Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal.尼泊尔内脏利什曼病后皮肤利什曼病(PKDL)的流行情况和 PKDL 患者的求医行为。
PLoS Negl Trop Dis. 2023 Feb 9;17(2):e0011138. doi: 10.1371/journal.pntd.0011138. eCollection 2023 Feb.
6
[Generalized old world leishmaniasis: first Moroccan case in an immunocompetent adult?].[播散性旧世界利什曼病:首例免疫功能正常成人的摩洛哥病例?]
Med Trop Sante Int. 2021 Nov 5;1(4). doi: 10.48327/mtsi.2021.90. eCollection 2021 Dec 31.
7
Identification of asymptomatic Leishmania infections: a scoping review.无症状利什曼原虫感染的鉴定:范围综述。
Parasit Vectors. 2022 Jan 5;15(1):5. doi: 10.1186/s13071-021-05129-y.
8
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.通过在印度比哈尔邦实施基于卫生机构的哨点监测系统,改善黑热病病例管理。
PLoS Negl Trop Dis. 2021 Aug 24;15(8):e0009598. doi: 10.1371/journal.pntd.0009598. eCollection 2021 Aug.
9
A review of the leishmanin skin test: A neglected test for a neglected disease.利什曼素皮试评价:被忽视疾病的被忽视检测。
PLoS Negl Trop Dis. 2021 Jul 22;15(7):e0009531. doi: 10.1371/journal.pntd.0009531. eCollection 2021 Jul.
10
Mathematical modelling of the use of insecticide-treated nets for elimination of visceral leishmaniasis in Bihar, India.印度比哈尔邦使用杀虫剂处理过的蚊帐消除内脏利什曼病的数学模型
R Soc Open Sci. 2021 Jun 30;8(6):201960. doi: 10.1098/rsos.201960. eCollection 2021 Jun.
印度次大陆内脏利什曼病控制中的寻医行为、诊断和传播动态。
Nature. 2015 Dec 3;528(7580):S102-8. doi: 10.1038/nature16042.
4
Quantification of the natural history of visceral leishmaniasis and consequences for control.内脏利什曼病自然史的量化及其对控制的影响。
Parasit Vectors. 2015 Oct 22;8:521. doi: 10.1186/s13071-015-1136-3.
5
Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts.尼泊尔东部山区杜氏利什曼原虫的传播:奥卡尔东加和博杰普尔地区的疫情调查
PLoS Negl Trop Dis. 2015 Aug 7;9(8):e0003966. doi: 10.1371/journal.pntd.0003966. eCollection 2015.
6
Uniting mathematics and biology for control of visceral leishmaniasis.将数学和生物学结合起来控制内脏利什曼病。
Trends Parasitol. 2015 Jun;31(6):251-9. doi: 10.1016/j.pt.2015.03.007. Epub 2015 Apr 22.
7
Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?印度北部无症状利什曼原虫感染:对消除计划的威胁?
Trans R Soc Trop Med Hyg. 2014 Nov;108(11):679-84. doi: 10.1093/trstmh/tru146. Epub 2014 Sep 9.
8
Parasite load estimation by qPCR differentiates between asymptomatic and symptomatic infection in Indian visceral leishmaniasis.通过定量聚合酶链反应(qPCR)估计寄生虫负荷可区分印度内脏利什曼病的无症状感染和有症状感染。
Diagn Microbiol Infect Dis. 2014 Sep;80(1):40-2. doi: 10.1016/j.diagmicrobio.2014.01.031. Epub 2014 Mar 7.
9
Impact of ASHA training on active case detection of visceral leishmaniasis in Bihar, India.印度比哈尔邦阿莎培训对内脏利什曼病主动病例检测的影响。
PLoS Negl Trop Dis. 2014 May 22;8(5):e2774. doi: 10.1371/journal.pntd.0002774. eCollection 2014 May.
10
Asymptomatic Leishmania infection: a new challenge for Leishmania control.无症状利什曼原虫感染:利什曼原虫控制面临的新挑战。
Clin Infect Dis. 2014 May;58(10):1424-9. doi: 10.1093/cid/ciu102. Epub 2014 Feb 27.